|

PM54 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • PharmaMar2

Indications

  • Cancer2
  • Advanced Malignancies1
  • Advanced Solid Tumor1

New York, New York1 trial

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

START New York

Phase 1/2

San Antonio, Texas1 trial

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

South Texas Accelerated Research Therapeutics

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.